Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Pharmacology and Toxicology

  • Subscribe to feed (RSS)

Showing page 8 of 22 pages of list content

  • Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants

    This article's authors
    1. Lianghui Zhang
    2. Soumajit Dutta
    3. Shiqin Xiong
    4. Matthew Chan
    5. Kui K. Chan
    6. Timothy M. Fan
    7. Keith L. Bailey
    8. Matthew Lindeblad
    9. Laura M. Cooper
    10. Lijun Rong
    11. Anthony F. Gugliuzza
    12. Diwakar Shukla
    13. Erik Procko
    14. Jalees Rehman
    15. Asrar B. Malik
    This article has 1 evaluations Latest evaluation on Dec 24, 2021 Published on Dec 22, 2021
  • Fluorescence Activation Mechanism and Imaging of Drug Permeation with New Sensors for Smoking-Cessation Ligands

    This article's authors
    1. Aaron L. Nichols
    2. Zack Blumenfeld
    3. Chengcheng Fan
    4. Laura Luebbert
    5. Annet E. M. Blom
    6. Bruce N. Cohen
    7. Jonathan S. Marvin
    8. Philip M. Borden
    9. Charlene H. Kim
    10. Anand K. Muthusamy
    11. Amol V. Shivange
    12. Hailey J. Knox
    13. Hugo Rego Campello
    14. Jonathan H. Wang
    15. Dennis A. Dougherty
    16. Loren L. Looger
    17. Timothy Gallagher
    18. Douglas C. Rees
    19. Henry A. Lester
    This article has 4 evaluations Latest evaluation on Dec 23, 2021 Published on Dec 18, 2021
  • Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2

    This article's authors
    1. Changzhi Li
    2. Hongjuan Zhou
    3. Lingling Guo
    4. Dehuan Xie
    5. Huiping He
    6. Hong Zhang
    7. Yixiu Liu
    8. Lixia Peng
    9. Lisheng Zheng
    10. Wenhua Lu
    11. Yan Mei
    12. Zhijie Liu
    13. Jie Huang
    14. Mingdian Wang
    15. Ditian Shu
    16. Liuyan Ding
    17. Yanhong Lang
    18. Feifei Luo
    19. Jing Wang
    20. Bijun Huang
    21. Peng Huang
    22. Song Gao
    23. Jindong Chen
    24. Chao-Nan Qian
    This article has 1 evaluations Latest evaluation on Dec 18, 2021 Published on Dec 15, 2021
  • The Petasites hybridus CO2-extract (Ze 339) blocks SARS-CoV-2 replication in vitro

    This article's authors
    1. Lorena Urda
    2. Matthias Heinrich Kreuter
    3. Jürgen Drewe
    4. Georg Boonen
    5. Veronika Butterweck
    6. Thomas Klimkait
    This article has 1 evaluations Latest evaluation on Dec 10, 2021 Published on Dec 7, 2021
  • Remodeling of dermal adipose tissue alleviates cutaneous toxicity induced by anti-EGFR therapy

    This article's authors
    1. Leying Chen
    2. Qing You
    3. Min Liu
    4. Shuaihu Li
    5. Zhaoyu Wu
    6. Jiajun Hu
    7. Liangyong Xia
    8. Shiyi Zhang
    This article has 4 evaluations Latest evaluation on Jan 21, 2022 Published on Nov 19, 2021
  • Drug repurposing screening identified tropifexor as a SARS-CoV-2 papain-like protease inhibitor

    This article's authors
    1. Chunlong Ma
    2. Yuyin Wang
    3. Juliana Choza
    4. Jun Wang
    This article has 1 evaluations Latest evaluation on Dec 6, 2021 Published on Dec 3, 2021
  • Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo

    This article's authors
    1. Otávio Augusto Chaves
    2. Carolina Q. Sacramento
    3. André C. Ferreira
    4. Mayara Mattos
    5. Natalia Fintelman-Rodrigues
    6. Jairo R. Temerozo
    7. Douglas Pereira Pinto
    8. Gabriel P. E. da Silveira
    9. Laís Bastos da Fonseca
    10. Heliana Martins Pereira
    11. Aluana Santana Carlos
    12. Joana da Costa Pinto d’Ávila
    13. João P.B. Viola
    14. Robson Q. Monteiro
    15. Leonardo Vazquez
    16. Patrícia T. Bozza
    17. Hugo Caire Castro-Faria-Neto
    18. Thiago Moreno L. Souza
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 24, 2021
  • Hypertonic saline and aprotinin based blockage of SARS-CoV-2 specific furin site cleavage by inhibition of nasal protease activity

    This article's authors
    1. Clarissa Li
    2. Adam W. Li
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 22, 2021
  • Dual Effects of Nanoviricides Platform Technology Based NV-CoV-2 Biomimetic Polymer Against COVID-19

    This article's authors
    1. Anil Diwan
    2. Ashok Chakraborty
    3. Vijetha Chiniga
    4. Vinod Arora
    5. Preetam Holkar
    6. Yogesh Thakur
    7. Jay Tatake
    8. Randall Barton
    9. Neelam Holkar
    10. Bethany Pond
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 26, 2021
  • Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo

    This article's authors
    1. Ashok Chakraborty
    2. Anil Diwan
    3. Vinod Arora
    4. Yogesh Thakur
    5. Vijetha Chiniga
    6. Jay Tatake
    7. Preetam Holkar
    8. Neelam Holkar
    9. Bethany Pond
    This article has 1 evaluations Latest evaluation on Nov 23, 2021 Published on Nov 19, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information